Daniel Tassé is a businessperson who has been at the head of 5 different companies.
He is Chairman at Indivior PLC and Chief Executive Officer & Executive Director at DBV Technologies SA.
He is also on the board of BioQ Pharma, Inc., REGENXBIO, Inc. and Roundtable On Critical Care Policy.
He previously held the position of Director at Bellerophon Therapeutics, Inc., Chairman & Chief Executive Officer at Alcresta Therapeutics, Inc., Member of Healthcare Leadership Council, Vice President & Regional Director-Australasia at GlaxoSmithKline Plc, GM-Pharmaceuticals & Technologies Business Unit at Baxter International, Inc., Chairman, President & Chief Executive Officer of Ikaria, Inc., Chief Financial Officer at NRG Energy Ltd. and Director at Biotechnology Innovation Organization.
Daniel Tassé received an undergraduate degree from the University of Montréal.